Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab for pain in chronic prostatitis
NCT00826514Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2009
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of tanezumab in chronic prostatitis (CP), sponsored by Pfizer. Started Mar 2009; status: completed.
02
Drugs
tanezumab
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on NCT00826514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826514.